Gilbert, Arizona Clinical Trials

A listing of Gilbert, Arizona clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 37 clinical trials
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

This study is being done to see if tucatinib with ado-trastuzumab emtansine (T-DM1) works better than T-DM1 alone to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma. The breast cancer in this study is either metastatic (spread into other parts of the body) …

Banner MD Anderson Cancer Center
 (2.4 away) Contact site
  • 0 views
  • 14 Mar, 2022
  • +227 other locations
A Study of LY3819253 (LY-CoV555) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 works against the virus that causes COVID-19. LY3819253 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus …

dyspnea
heart disease
covid-19
throat
body mass index
Arizona Clin Trials-Mesa
 (4.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +61 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

florbetapir
positron emission tomography
flortaucipir
alzheimer's disease
mini-mental state examination
Gilbert Neurology
 (6.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +85 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

treatment regimen
preventive medication
lasmiditan
ly573144
headache
Clinical Research Consortium
 (8.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +162 other locations
Multi-center Open-label Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)

Primary Objectives: To evaluate the safety and tolerability of isatuximab administered subcutaneously (SC) versus intravenously (IV) To evaluate the pharmacokinetics (PK) of SC and IV isatuximab Secondary Objectives: To estimate absolute bioavailability of SC and IV isatuximab To measure receptor occupancy (RO) after isatuximab SC versus IV administration To assess …

tuberculosis
dexamethasone
hepatitis b surface antigen
antibiotic
corticosteroids
Investigational Site Number 8400005
 (2.4 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +12 other locations
PTI-125 100 mg for Mild-to-moderate Alzheimer's Disease Patients

An Open-label study for patients who completed the previous studies, PTI-125-02 or PTI-125-03. Additional new patients will be included for a total of 100 patients enrolled for this study.

amyloidosis
memantine
positron emission tomography
mini-mental state examination
galantamine
Cognitive Clinical Trials
 (3.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +8 other locations
Registry of Asthma Patients Initiating DUPIXENT

The primary objective of the study is to characterize the patients who initiate treatment for asthma with DUPIXENT in a real-world setting. The secondary objectives of the study are: To characterize real-world use patterns of DUPIXENT for asthma To assess the long-term effectiveness of DUPIXENT in asthma patients in a …

Regeneron Study Site
 (2.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location